HUTCHMED (China) Ltd·4

May 21, 6:11 AM ET

Nixon Charles George Rupert 4

Research Summary

AI-generated summary

Updated

HUTCHMED (HCM) Group GC Charles Nixon Receives Awarded Shares

What Happened
Charles George Rupert Nixon, Group General Counsel of HUTCHMED (HCM), was allocated a total of 15,089 ordinary shares (7,445 + 7,644) on May 20, 2026 under the company's Long Term Incentive Plan. Both allocations were recorded as derivative acquisitions at a purchase price of $0.00 (total reported cash value $0), reflecting award allocations after achievement of FY2025 performance conditions.

Key Details

  • Transaction date: 2026-05-20; Form 4 filed: 2026-05-21.
  • Amounts: 7,445 shares (grant from Aug 5, 2024 award) and 7,644 shares (grant from Jun 9, 2025 award); total 15,089 shares.
  • Price reported on Form 4: $0.00 (allocated at no purchase price). Form value therefore shown as $0 on the filing.
  • Shares are held by the LTIP trustee on behalf of the Reporting Person (derivative holdings; code J).
  • Vesting/transfer timing: the first tranche is expected to vest and be transferred in 2027 (F1), the second in 2028 (F2), subject to award terms and conditions.
  • Shares owned after the transaction: not specified in the information provided.
  • Filing timeliness: filed the business day after the transaction; no late filing flag indicated.

Context
These were awards granted/allocated under HUTCHMED's Long Term Incentive Plan following FY2025 performance results, not open-market purchases or sales. The allocations are held by a trustee and are expected to vest in future years; they represent compensation and future interest in ordinary shares rather than an immediate cash transaction. The Form 4 shows a $0 purchase price for reporting purposes; it does not report any immediate sale or cashless exercise.